Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Mével M, Kamaly N, Carmona S, Oliver MH, Jorgensen MR, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Yaouanc JJ, Jaffrès PA, Miller AD.

J Control Release. 2010 Apr 19;143(2):222-32. doi: 10.1016/j.jconrel.2009.12.001. Epub 2009 Dec 5.

PMID:
19969034
2.

Aflatoxin B1 and/or hepatitis B virus induced tumor spectrum in a genetically engineered hepatitis B virus expression and Trp53 haploinsufficient mouse model system for hepatocarcinogenesis.

Cullen JM, Brown DL, Kissling GE, Foley JF, Rizzo J, Marion PL, Parron VI, French JE.

Toxicol Pathol. 2009 Apr;37(3):333-42. doi: 10.1177/0192623309333137. Epub 2009 Mar 2.

PMID:
19258306
3.

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.

Carmona S, Jorgensen MR, Kolli S, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Miller AD.

Mol Pharm. 2009 May-Jun;6(3):706-17. doi: 10.1021/mp800157x.

PMID:
19159285
4.

Harderian gland neoplasms in captive, wild-caught Beechey ground squirrels (Spermophilus beecheyi).

Ranck RS, Cullen JM, Waggie KS, Marion PL.

Vet Pathol. 2008 May;45(3):388-92. doi: 10.1354/vp.45-3-388.

PMID:
18487500
5.

Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.

Rauschhuber C, Xu H, Salazar FH, Marion PL, Ehrhardt A.

J Gene Med. 2008 Aug;10(8):878-89. doi: 10.1002/jgm.1207.

PMID:
18470951
6.

Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.

Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL, Ferry N, Weinberg MS, Arbuthnot P.

Mol Ther. 2006 Feb;13(2):411-21. Epub 2005 Dec 5.

7.

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

Bordier BB, Ohkanda J, Liu P, Lee SY, Salazar FH, Marion PL, Ohashi K, Meuse L, Kay MA, Casey JL, Sebti SM, Hamilton AD, Glenn JS.

J Clin Invest. 2003 Aug;112(3):407-14.

8.

Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.

Foster WK, Miller DS, Marion PL, Colonno RJ, Kotlarski I, Jilbert AR.

Antimicrob Agents Chemother. 2003 Aug;47(8):2624-35.

9.

Inhibition of hepatitis B virus in mice by RNA interference.

McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Marion PL, Kay MA.

Nat Biotechnol. 2003 Jun;21(6):639-44. Epub 2003 May 12.

PMID:
12740585
10.

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Bordier BB, Marion PL, Ohashi K, Kay MA, Greenberg HB, Casey JL, Glenn JS.

J Virol. 2002 Oct;76(20):10465-72.

11.

Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication.

Marion PL, Salazar FH, Winters MA, Colonno RJ.

Antimicrob Agents Chemother. 2002 Jan;46(1):82-8.

12.

Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.

Ohashi K, Marion PL, Nakai H, Meuse L, Cullen JM, Bordier BB, Schwall R, Greenberg HB, Glenn JS, Kay MA.

Nat Med. 2000 Mar;6(3):327-31.

PMID:
10700236
13.

Demodex sp. in California ground squirrels.

Waggie KS, Marion PL.

J Wildl Dis. 1997 Apr;33(2):368-70.

PMID:
9131580
14.
16.
17.
19.

A cell surface protein that binds avian hepatitis B virus particles.

Kuroki K, Cheung R, Marion PL, Ganem D.

J Virol. 1994 Apr;68(4):2091-6.

20.

Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.

Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia MA.

Proc Natl Acad Sci U S A. 1992 May 1;89(9):3874-8.

22.

Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture.

Hung LF, Brumbaugh AE, Bhatia G, Marion PL, Hung PP, Norbeck DW, Plattner JJ, Robinson WS.

J Med Virol. 1991 Nov;35(3):180-6.

PMID:
1804929
23.

Comparative sequence analysis of defective and infectious avian hepadnaviruses.

Sprengel R, Schneider R, Marion PL, Fernholz D, Wildner G, Will H.

Nucleic Acids Res. 1991 Aug 11;19(15):4289. No abstract available.

24.

Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide.

Yuasa S, Cheung RC, Pham Q, Robinson WS, Marion PL.

Virology. 1991 Mar;181(1):14-21.

PMID:
1704654
25.

Development of antiviral therapy for chronic infection with hepatitis B virus.

Marion PL.

Curr Top Microbiol Immunol. 1991;168:167-83. Review. No abstract available.

PMID:
1893776
26.

Hepadnaviruses and hepatocellular carcinoma.

Sherker AH, Marion PL.

Annu Rev Microbiol. 1991;45:475-507. Review. No abstract available.

PMID:
1660256
27.

Open reading frames on plus strand genome of duck hepatitis B virus.

Tagawa M, Omata M, Marion PL.

Gastroenterol Jpn. 1990 Sep;25 Suppl 2:20-2.

PMID:
2227263
28.

Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks.

Cullen JM, Marion PL, Sherman GJ, Hong X, Newbold JE.

Cancer Res. 1990 Jul 1;50(13):4072-80.

29.

Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.

Cheung RC, Trujillo DE, Robinson WS, Greenberg HB, Marion PL.

Virology. 1990 Jun;176(2):546-52.

PMID:
1693247
30.

Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus.

Cheung RC, Robinson WS, Marion PL, Greenberg HB.

J Virol. 1989 Jun;63(6):2445-51.

31.

A sequential histologic and immunohistochemical study of duck hepatitis B virus infection in Pekin ducks.

Cullen JM, Marion PL, Newbold JE.

Vet Pathol. 1989 Mar;26(2):164-72.

PMID:
2540586
32.

Use of animal models to study hepatitis B virus.

Marion PL.

Prog Med Virol. 1988;35:43-75. Review. No abstract available.

PMID:
3051133
33.
34.

Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese.

Marion PL, Cullen JM, Azcárraga RR, Van Davelaar MJ, Robinson WS.

Hepatology. 1987 Jul-Aug;7(4):724-31.

PMID:
3610050
35.

Duck hepatitis B virus replicates in the yolk sac of developing embryos.

Tagawa M, Robinson WS, Marion PL.

J Virol. 1987 Jul;61(7):2273-9.

36.

Hepadnaviruses and retroviruses share genome homology and features of replication.

Robinson WS, Miller RH, Marion PL.

Hepatology. 1987 Jan-Feb;7(1 Suppl):64S-73S.

PMID:
3804216
37.

The role of hepadnaviruses in hepatocellular carcinoma.

Robinson WS, Miller RH, Marion PL.

Pharmacol Ther. 1987;35(1-2):1-26. Review. No abstract available.

PMID:
2827197
38.

Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus.

Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS.

Proc Natl Acad Sci U S A. 1986 Jun;83(12):4543-6.

41.

The hepadna viruses of animals.

Robinson WS, Marion PL, Miller RH.

Semin Liver Dis. 1984 Nov;4(4):347-60. Review. No abstract available.

PMID:
6395343
42.

Liver disease associated with duck hepatitis B virus infection of domestic ducks.

Marion PL, Knight SS, Ho BK, Guo YY, Robinson WS, Popper H.

Proc Natl Acad Sci U S A. 1984 Feb;81(3):898-902.

43.

Major polypeptide of duck hepatitis B surface antigen particles.

Marion PL, Knight SS, Feitelson MA, Oshiro LS, Robinson WS.

J Virol. 1983 Nov;48(2):534-41.

45.

Ground squirrel hepatitis virus infection.

Marion PL, Knight SS, Salazar FH, Popper H, Robinson WS.

Hepatology. 1983 Jul-Aug;3(4):519-27. No abstract available.

PMID:
6862363
46.

Hepadna viruses: hepatitis B and related viruses.

Marion PL, Robinson WS.

Curr Top Microbiol Immunol. 1983;105:99-121. Review. No abstract available.

PMID:
6354611
50.

Supplemental Content

Loading ...
Support Center